Intradiscal Gelified Ethanol and Pulsed Radiofrequency Versus Gelified Ethanol Injection for Discogenic Low Back Pain
CompletedNot applicableNCT02343484
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Many different minimally invasive techniques have been used for the treatment of chronic discogenic low back pain refractory to conservative treatments, with various results. The aim of this study is to assess the efficacy of the combination of intradiscal pulsed radiofrequency and gelified ethanol versus gelified ethanol alone, on pain and quality of life of patients sufferring from chronic discogenic low back pain.
Study details
- Official title
- Intradiscal Combination of Gelified Ethanol and Pulsed Radiofrequency Versus Gelified Ethanol Injection for the Treatment of Chronic Discogenic Low Back Pain. A Randomized Controlled Trial.
- Conditions
- Interventions
- Drug: Gelified ethanol combined to pulsed radiofrequency
- Drug: Gelified ethanol
- Sponsor
- Attikon Hospital
- Start date
- 2013-03
- Primary completion
- 2017-09
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Greece
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Discogenic low back pain \> 6 months, * pain refractory to conservative treatment, * no other aetiology for pain, * pain reported during provocative discography according to standard criteria, * MRI imaging indicating disk degenarative disease Exclusion Criteria: * Red flags for low back pain, * lumbosacral radiculopathy, * extruded or sequestered lumbar disc, * severe spinal stenosis, * facet joint syndrome, * sacroiliac joint pain, * neurological disorders, * psychiatric disorders, * rheumatoid arhtritis, ancylosing spondylitis, other autoimmune arthritis, * coagulation disorders, * pregnancy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02343484